medigraphic.com
SPANISH

Ginecología y Obstetricia de México

Federación Mexicana de Ginecología y Obstetricia, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2023, Number 08

<< Back

Ginecol Obstet Mex 2023; 91 (08)

Uterine arteriovenous malformation as a cause of late puerperal hemorrhage

Fernández CC, García JR, Valero I, Ariza EEM
Full text How to cite this article

Language: Spanish
References: 22
Page: 631-636
PDF size: 211.56 Kb.


Key words:

Uterine arteriovenous malformation, Puerperal hemorrhage, Uterine artery embolization, Hysterectomy.

ABSTRACT

Background: Uterine arteriovenous malformations are a rare cause of puerperal hemorrhage, with only 150 cases reported in the literature. Their knowledge is important because they are life-threatening and because there has been an increase in recent years. They are usually related to interventions in the uterus: curettage, caesarean section or myomectomy or associated with neoplasms (gestational trophoblastic disease or endometrial adenocarcinoma), although others are congenital.
Clinical case: A 32-year-old patient with a cervical conization and ablation of a uterine myoma by radiofrequency as the only history of interest. Fifteen days after a euthecological delivery, which was the first in her history, she had an episode of abundant metrorrhagia. In the immediate postpartum period, she had a heavy hemorrhage that required the transfusion of two red blood cell concentrates. Transvaginal ultrasound showed a uterus measuring 22 x 44 mm, which could correspond to a retained cotyledon. In view of the persistent bleeding, intracavitary tamponade was placed with a Foley catheter, which led to cessation of bleeding. After ruling out embolization of the uterine arteries due to the large size of the arteriovenous malformation, a simple total hysterectomy by laparotomy was performed.
Conclusion: Uterine arteriovenous malformations, although an infrequent cause of puerperal hemorrhage, should be suspected because they are potentially fatal.


REFERENCES

  1. Szpera-Goździewicz A, Gruca-Stryjak K, Bręborowicz GH,Ropacka-Lesiak M. Uterine arteriovenous malformation:diagnosis and management. Ginekol Pol 2018; 89 (5): 276-79. https://doi.org/10.5603/GP.a2018.0047

  2. Hammad R, Nausheen S, Malik M. A Case series on uterinearteriovenous malformations: a life-threatening emergencyin young women. Cureus 2020; 12 (7): e9410. https://doi.org/10.7759/cureus.9410.

  3. Gan F, Vikneswaran V, Yu KK. Uterine arteriovenous malformation.Possible association to uterine fibroids? Med JMalaysia 2021; 76 (2): 273-4.

  4. Zhu YP, Sun ZJ, Lang JH, Pan J. Clinical characteristic andmanagement of acquired uterine arteriovenous malformation.Chin Med J (Engl) 2018; 131 (20): 2489-91. https://doi.org/10.4103/0366-6999.243570

  5. Shim DJ, Choi SJ, Jung JM, Choi JH. Uterine arteriovenousmalformation with repeated vaginal bleeding after dilatationand curettage. Obstet Gynecol Sci 2019; 62 (2): 142-5.https://doi.org/10.5468/ogs.2019.62.2.142

  6. Godoy LL, Torres US, D'Ippolito G. Subinvolution of theplacental site associated with focal retained productsof conception and placenta accreta mimicking uterinearteriovenous malformation on CT and MRI: a lesson tobe learned. Radiol Bras 2018; 51 (2): 135-6. https://doi.org/10.1590/0100-3984.2016.0131

  7. Chughtai F, Ahmed M, Alam AM. Uterine arterio-venousmalformation, an uncommon life-threatening condition: acase report. J Pak Med Assoc 2020; 70 (3): 531-33. https://doi.org/10.5455/JPMA.9800

  8. Menon BE, Kaufman CS, Kennedy AM, Ingraham CR, et al.Postpartum hemorrhage - what the interventional radiologistshould know. CVIR Endovasc 2021; 4 (1): 86. https://doi.org/10.1186/s42155-021-00277-9

  9. Groszmann YS, Healy Murphy AL, Benacerraf BR. Diagnosisand management of patients with enhanced myometrialvascularity associated with retained products of conception.Ultrasound Obstet Gynecol 2018; 52 (3): 396-39.https://doi.org/10.1002/uog.18954

  10. Rampersad F, Narine S, Rampersad D, Diljohn J, et al. Uterinearteriovenous malformation mimicking retained products ofconception: treated with embolization. Radiol Case Rep 2020;15 (11): 2076-79. https://doi.org/10.1016/j.radcr.2020.08.048

  11. Lollie TK, Raman SS, Qorbani A, Farzaneh T, et al. Rare occurrenceof uterine arteriovenous malformation clinicallymimicking a malignant growth: A critical reminder forpathologists. Autops Case Rep 2020; 10 (3): e2020144.https://doi.org/10.4322/acr.2020.144

  12. Moynihan HV, Richardson J, Loveridge K. Fertility-preservingmanagement of uterine arteriovenous malformationin a 16-year-old female. Cureus 2021; 13 (9): e18162.https://doi.org/10.7759/cureus.18162.

  13. Timmerman D, Bosch TVd, Peeraer K. Vascular malformationsin the uterus: ultrasonographic diagnosis andconservative management. Euro J Obstet Gynaecol ReprodBiol 2000; 92: 171-78.

  14. Vyas S, Choi HH, Whetstone S, Jha P, et al. Ultrasound featureshelp identify patients who can undergo noninvasive managementfor suspected retained products of conception:a single institutional experience. Abdom Radiol 2021; 46(6): 2729-39. https://doi.org/10.1007/s00261-020-02948-y

  15. Calzolari S, Cozzolino M, Castellacci E, Dubini V, et al.Hysteroscopic Management of Uterine ArteriovenousMalformation. JSLS 2017; 21 (2): e2016.00109. https://doi.org/10.4293/JSLS.2016.00109

  16. Evans A, Gazaille RE, McKenzie R, Musser M, et al. Acquireduterine arteriovenous fistula following dilatation andcurettage: an uncommon cause of vaginal bleeding. RadiolCase Rep 2017; 12 (2): 287-91. https://doi.org/10.1016/j.radcr.2017.01.005

  17. Delplanque S, Le Lous M, Proisy M, Joueidi Y, et al. Fertility,pregnancy, and clinical outcomes after uterine arteriovenousmalformation management. J Minim InvasiveGynecol 2019; 26 (1): 153-61. https://doi.org/10.1016/j.jmig.2018.05.001

  18. Javed A, Sheikh S. Pregnancy after embolization forarteriovenous malformation: An uncommon successfuloutcome. J Pak Med Assoc 2021; 71 (3): 1020-1. https://doi.org/10.47391/JPMA.246

  19. Ho CY, Seow KM, Huang LW, Tsai YL. Fertility outcomesfollowing pelvic embolization in women with acquireduterine arteriovenous malformation. Taiwan J ObstetGynecol 2017; 56 (6): 831-35. https://doi.org/10.1016/j.tjog.2017.10.023

  20. Zhang XQ, Chen XT, Zhang YT, Mai CX. The emergent pelvicartery embolization in the management of postpartumhemorrhage: a systematic review and meta-analysis.Obstet Gynecol Surv 2021; 76 (4): 234-44. https://doi.org/10.1097/OGX.0000000000000887

  21. Khan S, Saud S, Khan I, Achakzai B. Acquired uterinearteriovenous malformation following dilatation and curettagetreated with bilateral uterine artery embolization:a case report. Cureus 2019; 11 (3): e4250. https://doi.org/10.7759/cureus.4250

  22. Barral PA, Saeed-Kilani M, Tradi F, Dabadie A, et al. Transcatheterarterial embolization with ethylene vinyl alcoholcopolymer (Onyx) for the treatment of hemorrhage dueto uterine arteriovenous malformations. Diagn IntervImaging 2017; 98 (5): 415-21. https://doi.org/10.1016/j.diii.2016.09.003




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ginecol Obstet Mex. 2023;91